Evaluation of Vitamin D3 Level, Anti-CCP And Some Inflammatory Markers in Women with Rheumatoid Arthritis in Al-Hawija District, Kirkuk Governorate
Article Sidebar
-
Rheumatoid arthritis, Anti-Cyclic citrullinated peptide, C-Reactive protein, Erythrocyte sedimentation Rate
Abstract
The present study aimed to know the role of rheumatoid arthritis on the level of Anti-Cyclic citrullinated peptide (ACCP), C-Reactive protein (C-RP), Erythrocyte sedimentation Rate (ESR), and vitamin D3 in patients with rheumatoid arthritis in Al-Hawija district, Kirkuk governorate. The experiment included 50 samples, 25 of which were infected with this disease, which is the second group, and 25 healthy, which is the first group. The ages of the experiment samples ranged between 50-60 years. After ensuring that they were free from other chronic diseases, the samples were collected. "The results of the current study revealed a significant increase (P≤0.05) in the level of ACCP in patients compared to healthy women, while the results of the current study indicated a significant increase (P≤0.05) in the level of C-RP in patients compared to healthy women. The current study also revealed a substantial (P≤0.05) increase in the patients' ESR level when compared to healthy women, as well as a significant (P≤0.05) drop in the patients' vitamin D3 level when compared to healthy women. It can be concluded from the results of the current study that those infected are exposed to immunodeficiency and the disease may cause osteoporosis due to the low level of vitamin D3".
Full text article
References
Brown, P., Pratt, A. G., & Hyrich, K. L. (2024). Therapeutic advances in rheumatoid arthritis. bmj, 384.
Almutairi, K., Nossent, J., Preen, D., Keen, H., & Inderjeeth, C. (2021). The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatology international, 41(5), 863-877.
Mousavi, M. J., Karami, J., Aslani, S., Tahmasebi, M. N., Vaziri, A. S., Jamshidi, A., ... & Mahmoudi, M. (2021). Transformation of fibroblast‐like synoviocytes in rheumatoid arthritis; from a friend to foe. Autoimmunity Highlights, 12, 1-13.
Masoumi, M., Bashiri, H., Khorramdelazad, H., Barzaman, K., Hashemi, N., Sereshki, H. A., ... & Karami, J. (2021). Destructive roles of fibroblast-like synoviocytes in chronic inflammation and joint damage in rheumatoid arthritis. Inflammation, 44, 466-479.
Ramos‐Remus, C., Castillo‐Ortiz, J. D., Aguilar‐Lozano, L., Padilla‐Ibarra, J., Sandoval‐Castro, C., Vargas‐Serafin, C. O., ... & Aceves‐Avila, F. J. (2015). Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease. Arthritis & rheumatology, 67(11), 2837-2844.
Kongpachith, S., Lingampalli, N., Ju, C. H., Blum, L. K., Lu, D. R., Elliott, S. E., ... & Robinson, W. H. (2019). Affinity maturation of the anti–citrullinated protein antibody paratope drives epitope spreading and polyreactivity in rheumatoid arthritis. Arthritis & Rheumatology, 71(4), 507-517.
Toes, R. E., & Huizinga, T. J. (2015). Update on autoantibodies to modified proteins. Current Opinion in Rheumatology, 27(3), 262-267.
Gan, R. W., Bemis, E. A., Demoruelle, M. K., Striebich, C. C., Brake, S., Feser, M. L., ... & Norris, J. M. (2017). The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population. Rheumatology, 56(12), 2229-2236.
Hirose, W., Harigai, M., Amano, K., Hidaka, T., Itoh, K., Aoki, K., ... & TOF-ABT Study Group Akiyama Yuji Ando Souichirou Hashiba Yayoi Kaneko Motohide Kawagoe Mitsuhiro Kondo Tsuneo Kubo Kazuyoshi Masuda Ikuko Matsumoto Mitsuyo Okada Yusuke Shibata Akiko Suzuki Kimihiro Takamatsu Ko Takei Hirofumi. (2021). Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis. Arthritis Research & Therapy, 23(1), 228
Klareskog, L., Malmström, V., Lundberg, K., Padyukov, L., & Alfredsson, L. (2011, April). Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. In Seminars in immunology (Vol. 23, No. 2, pp. 92-98). Academic Press.
Liu, X., Tedeschi, S. K., Barbhaiya, M., Leatherwood, C. L., Speyer, C. B., Lu, B., ... & Sparks, J. A. (2019). Impact and timing of smoking cessation on reducing risk of rheumatoid arthritis among women in the nurses’ health studies. Arthritis care & research, 71(7), 914-924.
Lugli, E. B., Correia, R. E., Fischer, R., Lundberg, K., Bracke, K. R., Montgomery, A. B., ... & Venables, P. J. (2015). Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis. Arthritis research & therapy, 17, 1-8.
Al-Rawy, Khasha Mahmoud (2000) Introduction to Statistics, Second Edition, College of Agriculture and Forestry, University of Mosul.
Abourazzak, F. E., Talbi, S., Aradoini, N., Berrada, K., Keita, S., & Hazry, T. (2015). 25-Hydroxy vitamin D and its relationship with clinical and laboratory parameters in patients with rheumatoid arthritis. Clinical rheumatology, 34, 353-357.
Harrison, S. R., Li, D., Jeffery, L. E., Raza, K., & Hewison, M. (2020). Vitamin D, autoimmune disease and rheumatoid arthritis. Calcified tissue international, 106, 58-75.
Franco, A. S., Freitas, T. Q., Bernardo, W. M., & Pereira, R. M. R. (2017). Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis. Medicine, 96(23), e7024.
Taylor, P. C. (2020). Update on the diagnosis and management of early rheumatoid arthritis. Clinical Medicine, 20(6), 561-564.
Radu, A. F., & Bungau, S. G. (2021). Management of rheumatoid arthritis: an overview. Cells, 10(11), 2857.
Steiner, G., Van Hoovels, L., Csige, D., Gatto, M., Iagnocco, A., & Szekanecz, Z. (2024). Should ACR/EULAR criteria be revised changing the RF and ACPA scores?. Autoimmunity Reviews, 23(1), 103421.
Batsalova, T., Teneva, I., Bardarov, K., Moten, D., & Dzhambazov, B. (2023). Anticitrullinated antibodies recognize rheumatoid arthritis associated T-cell epitopes modified by bacterial L-asparaginase. Central European Journal of Immunology, 48(1).
Zeng, P., Chen, Z., Klareskog, L., Alfredsson, L., Bengtsson, C., & Jiang, X. (2018). Amount of smoking, duration of smoking cessation and their interaction with silica exposure in the risk of rheumatoid arthritis among males: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study. Annals of the rheumatic diseases, 77(8), 1238-1241.
MARTÍNEZ-DONCEL, A. L. F. O. N. S. O., RODRÍGUEZ, E. U., & FERNÁNDEZ-GUTIÉRREZ, B. E. N. J. A. M. Í. N. (2009). Shared Epitope and Anti-Cyclic Citrullinated Peptide Antibodies: Relationship. The Journal of Rheumatology, 36(5), 1085-1086.
Fujita, Y., Asano, T., Matsuoka, N., Temmoku, J., Sato, S., Matsumoto, H., ... & Migita, K. (2020). Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients. Arthritis Research & Therapy, 22, 1-9.
Hirata, S., Dirven, L., Shen, Y., Centola, M., Cavet, G., Lems, W. F., ... & Allaart, C. F. (2013). A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Rheumatology, 52(7), 1202-1207.
Lee, S. A., Kang, S. B., Yoon, C., Chang, C. B., Chang, M. J., & Seo, J. G. (2019). Temporal value of C-reactive protein and erythrocyte sedimentation rate after total knee arthroplasty in patients with elevated preoperative C-reactive protein: a matched-pair analysis. Indian Journal of Orthopaedics, 53, 437-441.
Baki, N. M. A., Elgengehy, F. T., Zahran, A. M., Ghoniem, S., Elsayed, E., Medhat, A., ... & Elashmawy, H. (2022). Galectin-3 and interleukin-7 as potential serologic markers in rheumatoid arthritis patients. The Egyptian Rheumatologist, 44(4), 319-324.
Hu, Y., Yéléhé-Okouma, M., Ea, H. K., Jouzeau, J. Y., & Reboul, P. (2017). Galectin-3: A key player in arthritis. Joint Bone Spine, 84(1), 15-20.
Fadda, S., Abolkheir, E., Afifi, R., & Gamal, M. (2016). Serum matrix metalloproteinase-3 in rheumatoid arthritis patients: Correlation with disease activity and joint destruction. The Egyptian Rheumatologist, 38(3), 153-159.
Orr, C. K., Najm, A., Young, F., McGarry, T., Biniecka, M., Fearon, U., & Veale, D. J. (2018). The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis. Frontiers in medicine, 5, 185.
Siemons, L., Vonkeman, H. E., Ten Klooster, P. M., van Riel, P. L., & van de Laar, M. A. (2014). Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker. Clinical rheumatology, 33, 783-789.
Wintrobe, M. M., & Landsberg, J. W. (2013). Landmark Publication From The American Journal of the Medical Sciences: A Standardized Technique for the Blood Sedimentation Test. The American Journal of the Medical Sciences, 346(2), 148-153.
Authors
Copyright (c) 2024 Journal of Current Medical Research and Opinion
This work is licensed under a Creative Commons Attribution 4.0 International License.